Prescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Background: Ranitidine was the most prescribed histamine-2 receptor antagonist (H2RA) in
Canada when recalled in 2019 because of potential carcinogenicity. We sought to compare …
Canada when recalled in 2019 because of potential carcinogenicity. We sought to compare …
Ranitidine Use and Incident Cancer in a Multinational Cohort
Importance Ranitidine, the most widely used histamine-2 receptor antagonist (H 2 RA), was
withdrawn because of N-nitrosodimethylamine impurity in 2020. Given the worldwide …
withdrawn because of N-nitrosodimethylamine impurity in 2020. Given the worldwide …
Ranitidine use and cancer risk: results from UK Biobank
ED Kantor, K O'Connell, M Du, RB Mendelsohn… - …, 2021 - gastrojournal.org
Ranitidine Use and Cancer Risk: Results From UK Biobank - Gastroenterology Skip to Main
Content Advertisement Gastroenterology American Gastroenterological Association Home …
Content Advertisement Gastroenterology American Gastroenterological Association Home …
[HTML][HTML] Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European …
JT Arinze, MAJ de Ridder, D Vojinovic… - Drug Safety, 2023 - Springer
Introduction Ranitidine, a histamine H2-receptor antagonist (H2RA), is indicated in the
management of gastric acid-related disorders. In 2020, the European Medicines Agency …
management of gastric acid-related disorders. In 2020, the European Medicines Agency …
Risk of cancer in association with ranitidine and nizatidine vs other h2 blockers: Analysis of the japan medical data center claims database 2005–2018
M Iwagami, R Kumazawa, Y Miyamoto, Y Ito… - Drug Safety, 2021 - Springer
Abstract Introduction In September 2019, ranitidine and nizatidine were suggested to
contain N-nitrosodimethylamine, a carcinogenic substance. People have since been …
contain N-nitrosodimethylamine, a carcinogenic substance. People have since been …
Ranitidine use and risk of upper gastrointestinal cancers
HO Adami, I Trolle Andersen, U Heide-Jørgensen… - … Biomarkers & Prevention, 2021 - AACR
Background: The discovery that ranitidine is contaminated with N-nitrosodimethylamine, a
suspected human carcinogen, raises the hypothesis of a gastrointestinal carcinogenic effect; …
suspected human carcinogen, raises the hypothesis of a gastrointestinal carcinogenic effect; …
[HTML][HTML] Pharmacoepidemiological Research on N-Nitrosodimethylamine-contaminated ranitidine use and long-term cancer risk: a population-based longitudinal …
CH Wang, II Chen, CH Chen, YT Tseng - International Journal of …, 2022 - mdpi.com
Simple Summary There is a lack of published data regarding the association between N-
nitrosodimethylamine and human cancer risks. Hence, this study answers several questions …
nitrosodimethylamine and human cancer risks. Hence, this study answers several questions …
Ranitidine Use and Risk of Upper Gastrointestinal Cancers—Reply
HO Adami, IT Andersen, U Heide-Jørgensen… - … Biomarkers & Prevention, 2022 - AACR
We thank Dr. Karp for his interest in our study (1) and agree of course that randomized
controlled trials (RCT) are the ideal approach to eliminate confounding at baseline. But …
controlled trials (RCT) are the ideal approach to eliminate confounding at baseline. But …
[HTML][HTML] N-Nitrosodimethylamine-contaminated ranitidine and risk of cancer in South Korea: a nationwide cohort study
IK Yoo, DC Marshall, JY Cho, HW Yoo, SW Lee - Life Cycle, 2021 - elifecycle.org
Objective: On September 2019, the United States Food and Drug Administration announced
that some ranitidine products were contaminated with unacceptable levels of N …
that some ranitidine products were contaminated with unacceptable levels of N …
Ranitidine and risk of bladder and kidney cancer: a population-based cohort study
M Nørgaard, IT Andersen, U Heide-Jørgensen… - … Biomarkers & Prevention, 2022 - AACR
Background: In 2019, ranitidine was withdrawn due to high levels of N-
nitrosodimethylamine, a probable human carcinogen. The risk of bladder and kidney cancer …
nitrosodimethylamine, a probable human carcinogen. The risk of bladder and kidney cancer …